Activities per year
Activities 1981 2018
- 1 - 50 out of 53 results
- Start date (descending)
10+ Years’ Follow-up of a Danish 2-Year Treat-to-Target RCT in Patients with Early Rheumatoid Arthritis: Baseline Predictors of Functional and Radiographic Outcomes
Kim Hørslev-Petersen (Other)16. Nov 2016
Activity: Talks and presentations › Talks and presentations in private or public companies
Magnetic Resonance Imaging (MRI) Joint Space Narrowing Is an Independent Predictor of Radiographic and MRI Damage Progression in Patients with Early Rheumatoid Arthritis
Kim Hørslev-Petersen (Other)13. Nov 2016
Activity: Talks and presentations › Talks and presentations in private or public companies
Brugerinddragelse indenfor forskning og forskningsuddelingsstrategi
Kim Hørslev-Petersen (Lecturer)26. Oct 2015
Activity: Talks and presentations › Talks and presentations in private or public companies
Erfaringer med at involvere patienter direkte i forskningen
Kim Hørslev-Petersen (Lecturer)1. Oct 2015
Activity: Talks and presentations › Talks and presentations in private or public companies
ADAM17 AND GALECTIN-9 ARE CRITICAL REGULATORS OF LOCAL 4-1BB ACTIVITY AND DISEASE OUTCOME IN RHEUMATOID ARTHRITIS
Kim Hørslev-Petersen (Other)12. Jun 2015
Activity: Talks and presentations › Talks and presentations in private or public companies
POLYMORPHISMS IN THE FCN1 GENE CODING FOR M-FICOLIN ARE ASSOCIATED WITH DISEASE ACTIVITY, RADIOGRAPHIC DAMAGE AND ARE THE STRONGEST PREDICTORS OF DAS28 REMISSION IN 180 DMARD NAIVE EARLY RHEUMATOID ARTHRITIS PATIENTS
Kim Hørslev-Petersen (Other)11. Jun 2015
Activity: Talks and presentations › Talks and presentations in private or public companies
Registration of imaging data in a nationwide clinical registry (DANBIO). How to implement Larsen scoring in DANBIO.: Other imaging assessments that could be relevant to include in registries.
Kim Hørslev-Petersen (Lecturer)27. Feb 2015
Activity: Talks and presentations › Talks and presentations in private or public companies
Inflammatory vs. degenerative rheumatic diseases - Differential diagnosis and pitfalls: Diagnostic workout in clinical practice
Kim Hørslev-Petersen (Lecturer)26. Feb 2015
Activity: Talks and presentations › Talks and presentations in private or public companies
Lessons from CIMESTRA and OPERA: T2T in early rheumatoid arthritis. TREATMENT STRATEGES FOR RA - TODAY AND TOMORROW.
Kim Hørslev-Petersen (Lecturer)22. Sep 2014
Activity: Talks and presentations › Talks and presentations in private or public companies
OPERA. Kliniske data.
Kim Hørslev-Petersen (Lecturer)11. Sep 2014
Activity: Talks and presentations › Talks and presentations in private or public companies
Bedre patientkoordinering indenfor muskel-skeletsygdomme - erfaringer fra Gråsten Gigthospital
Kim Hørslev-Petersen (Lecturer)27. Jan 2014
Activity: Talks and presentations › Talks and presentations in private or public companies
Kong Christian X's Gigthospital og DUPAL projektet
Kim Hørslev-Petersen (Lecturer)25. Apr 2013
Activity: Talks and presentations › Talks and presentations in private or public companies
De nye kvalitetsindikatorer for leddegigt. Behandlingsprincippet for RA: Treat to target - er det let eller svært?
Kim Hørslev-Petersen (Lecturer)20. Mar 2013
Activity: Talks and presentations › Talks and presentations in private or public companies
Vigtigheden af hurtig diagnosticering og omgående, konsekvent behandling
Kim Hørslev-Petersen (Lecturer)25. Feb 2013
Activity: Talks and presentations › Talks and presentations in private or public companies
The new classification criteria of RA - how do they work and the role of imaging techniques
Kim Hørslev-Petersen (Lecturer)4. Sep 2012
Activity: Talks and presentations › Talks and presentations in private or public companies
The new classification criteria of RA - how do they work and the role of imaging techniques
Kim Hørslev-Petersen (Lecturer)4. Sep 2012
Activity: Talks and presentations › Talks and presentations in private or public companies
Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis: 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA)
Kim Hørslev-Petersen (Lecturer)2. Sep 2012
Activity: Talks and presentations › Talks and presentations in private or public companies
Remission rates increase substantially by adding Adalimumab to Methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis - 1-year results of investigator-initiated, dobuleblinded randomized clinical trial (OPERA)
Kim Hørslev-Petersen (Lecturer)2. Sep 2012
Activity: Talks and presentations › Talks and presentations in private or public companies
M-FICOLIN, AN ACTIVATOR OF THE COMPLEMENT SYSTEM, PREDICTS DAS28 REMISSION IN EARLY DMARD NÄIVE RHEUMATOID ARTHRITIS.
Kim Hørslev-Petersen (Lecturer)6. Jun 2012 → 9. Jun 2012
Activity: Talks and presentations › Talks and presentations in private or public companies
CIMESTRA Study: A large and Succesfull European Collaborative Trial
Kim Hørslev-Petersen (Lecturer)23. Feb 2012 → 25. Feb 2012
Activity: Talks and presentations › Talks and presentations in private or public companies
Forskning i leddegigt
Kim Hørslev-Petersen (Lecturer)2. Feb 2012
Activity: Talks and presentations › Talks and presentations in private or public companies
Leddegigt: Forskning med patienten i centrum. Hvad går de egentlig og laver dernede i Gråsten?
Kim Hørslev-Petersen (Lecturer)25. Nov 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
Leddegigt: Udvikling gennem 30 år
Kim Hørslev-Petersen (Lecturer)22. Sep 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
Leddegigt.: Udvikling gennem 30 år.
Kim Hørslev-Petersen (Lecturer)13. Sep 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
King Chr. X's hospital for rheumatic diseases and its research activities.
Kim Hørslev-Petersen (Lecturer)8. Sep 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
ACR/EULAR RA kriterier 2011. Anvendelighed i daglig praksis: Highlights in Rheumatology
Kim Hørslev-Petersen (Lecturer)3. Sep 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
IN DMARD AND STEROID NAIVE EARLY RHEUMATOID ARTHRITIS PATIENTS D-VITAMIN, METABOLITES AT BASELINE CORRELATED INVERSELY WITH 'THE NUMBER OF TENDER JOINTS', VAS PAIN, DAS28, HAQ AND CRP LEVELS (THE CIMESTRA-COHORT)
Kim Hørslev-Petersen (Lecturer)25. May 2011 → 28. May 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
IN DMARD AND STEROID NAIVE EARLY RHEUMATOID ARTHRITIS PATIENTS D-VITAMIN, METABOLITES AT BASELINE CORRELATE WITH INITIAL RADIOGRAPHIC STATUS OR RADIOGRAPHIC PROGRESSION OVER 5 YEARS (THE CIMESTRA-COHORT)
Kim Hørslev-Petersen (Lecturer)25. May 2011 → 28. May 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
NO AVAILABLE QUALITY INDICATOR SETS FOR ARTHRITIS TEAM REHABILITATION: RESULTS FROM A SYSTEMATIC LITERATURE SEARCH AND REVIEW
Kim Hørslev-Petersen (Lecturer)25. May 2011 → 28. May 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
PATIENT EDUCATION AS PART OF MULTIDISCIPLINARY TEAM CARE IN RHEUMATOID ARTHRITIS
Kim Hørslev-Petersen (Lecturer)25. May 2011 → 28. May 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
Short- and long-term effect of unguided, intra-articular injections with betamethasone in early rheumatoid arthritis.: Impact of joint area, repeated injections, MRI findings, Anti-CCP, IgM-RF and CRP
Kim Hørslev-Petersen (Lecturer)25. May 2011 → 28. May 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
The Efficacy of active Physiotherapy vs passive/no Intervention for Pain Relief in Patients with Rheumatoid Arthritis: A systematic literature review and metaanalysis
Kim Hørslev-Petersen (Lecturer)25. May 2011 → 28. May 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
THE ORGANIZATION OF FOLLOW-UP FOR OUTPATIENTS WITH RHEUMATOID ARTHRITIS AFFECTS SATISFACTION AND CONFIDENCE BUT NOT DISEASE ACTIVITY, PAIN OR FATIGUE
Kim Hørslev-Petersen (Lecturer)25. May 2011 → 28. May 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
Periarticular and generalised bone loss in patients with early rheumatoid arthritis (ERA): Influence of alendronate (AL) and glucocorticoid treatment, and disease activity
Kim Hørslev-Petersen (Lecturer)7. May 2011 → 11. May 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
Forskning ved Sygehus Sønderjylland
Kim Hørslev-Petersen (Lecturer)4. Mar 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
Erfaringer med de nye ACR/EULAR kriterier
Kim Hørslev-Petersen (Lecturer)12. Jan 2011
Activity: Talks and presentations › Talks and presentations in private or public companies
Review på ph.d. protokol
Kim Hørslev-Petersen (Other)2011
Activity: Talks and presentations › Talks and presentations in private or public companies
Behandling af leddegigt - jo før jo bedre
Kim Hørslev-Petersen (Lecturer)22. Apr 2010
Activity: Talks and presentations › Talks and presentations in private or public companies
Tidlig artrit klinik i Syddanmark
Kim Hørslev-Petersen (Lecturer)1. Apr 2010
Activity: Talks and presentations › Talks and presentations in private or public companies
Hvordan differentieres der mellem forskellige gigtmidler
Kim Hørslev-Petersen (Lecturer)16. Mar 2010
Activity: Talks and presentations › Talks and presentations in private or public companies
Management of diagnostic routine in a rheumatology clinic in Denmark Antinuclear antibodies
Kim Hørslev-Petersen (Lecturer)15. Mar 2010
Activity: Talks and presentations › Talks and presentations in private or public companies
Biomarkers in early rheumatoid arthritis
Kim Hørslev-Petersen (Speaker)1. Aug 2009 → 4. Aug 2009
Activity: Talks and presentations › Talks and presentations in private or public companies
Spondyloarthritis: - other aspects
Kim Hørslev-Petersen (Lecturer)26. Jun 2009
Activity: Talks and presentations › Talks and presentations in private or public companies
Tidlig diagnostik af leddegigt
Kim Hørslev-Petersen (Lecturer)16. Jun 2009
Activity: Talks and presentations › Talks and presentations in private or public companies
The Danish version of the Rheumatoid Arthritis Selv-Efficacy Questionnaire (RASE)
Kim Hørslev-Petersen (Speaker)10. Jun 2009 → 13. Jun 2009
Activity: Talks and presentations › Talks and presentations in private or public companies
Kliniske retningslinier for polymyalgia rheumatika og arteritis temporalis
Kim Hørslev-Petersen (Speaker)1. May 2009
Activity: Talks and presentations › Talks and presentations in private or public companies
Self-efficacy og reumatoid artrit:: Oversættelse og test af validitet, reliabilitet og sensitivitet af den danske version af Rheumatoid Arthritis Self-Efficacy Questionnaire (RASE)
Kim Hørslev-Petersen (Speaker)30. Apr 2009
Activity: Talks and presentations › Talks and presentations in private or public companies
Leddegigt og anti-CCP
Kim Hørslev-Petersen (Lecturer)17. Mar 2009
Activity: Talks and presentations › Talks and presentations in private or public companies
Anti-CCP and Rheumatoid arthritis
Kim Hørslev-Petersen (Lecturer)17. Jun 2008
Activity: Talks and presentations › Talks and presentations in private or public companies
Remission and Rheumatoid Arthritis: Data from 24 Countries in the QUEST-RA Study
Kim Hørslev-Petersen (Speaker)11. Jun 2008 → 14. Jun 2008
Activity: Talks and presentations › Talks and presentations in private or public companies